Generic Inhalers
August 23rd, 2019 | Clinical ConnectionsAs generic maintenance inhalers become more widely covered by insurances, the Clinical Pharmacy Team would like to remind you what is available to increase patient access to costly inhalers.
- To limit rejected claims, we recommend sending prescriptions as “fluticasone/salmeterol” 100/50, 250/50, or 500/50 DAW0; allowing the pharmacist to fill fluticasone/salmeterol Diskus, Wixela™ Inhub™ or Advair Diskus, based on whichever is covered and/or cheapest for the patient
- Consider adding “please dispense least expensive formulation” in the notes to the pharmacist, if your EMR allows
- Since fluticasone/salmeterol RespiClick® comes in different doses, prescriptions intended to be filled for this product must be written specifically: “fluticasone/salmeterol RespiClick” 55/14, 113/14 or 232/14
- Generic albuterol inhalers are also available and are most easily obtained when prescriptions are sent for “albuterol HFA” with “please dispense least expensive formulation” in the note to the pharmacist
New Methylphenidate Delayed/Extended Release Product (Jornay PM™):
- Approved August 2018
- “Claim to fame” is both delayed and extended release properties
- Dosed at night, delayed release until 6-12 hours later and extended release to last entire next day
- Taken with or without food, and capsule can be opened and contents sprinkled on applesauce for patients with swallowing difficulties
Things to keep in mind:
- Does not cause less insomnia than other stimulants, in fact up to 41% of people in clinical trials experienced some level of insomnia
- New and very expensive (approximate cash price for #30 20 mg capsules: $490)
- Likely to have minimal insurance coverage initially
- Coupon card from the manufacturer is limited to commercially-insured patients and will only cover a maximum of $125 each month
Questions about this information? Contact the Pharmacy Team.
